MEDICLIN Aktiengesellschaft (MED.DE)
EUR 2.9
(-2.03%)
EUR 2.9
(-2.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 75.21 Million | 34.63 Million | 81.96 Million | 118.69 Million | 69.59 Million | 29.67 Million |
| Net Income | -10.77 Million | 9.71 Million | 1.48 Million | -9.03 Million | 22.41 Million | 7.76 Million |
| Depreciation & Amortization | 86 Million | 71.4 Million | 73.65 Million | 77.34 Million | 71.17 Million | 22.28 Million |
| Deferred income taxes | -65 Thousand | -2.94 Million | -525 Thousand | -1.37 Million | -750 Thousand | -203 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -23.58 Million | -49.49 Million | 1.72 Million | 51.87 Million | -6.88 Million | -2.87 Million |
| Other non-cash items | 195.64 Million | 3.01 Million | 5.09 Million | -1.49 Million | -17.1 Million | 2.49 Million |
| Investing Cash Flow | -9.51 Million | -6.24 Million | -7.09 Million | -8.6 Million | -35.64 Million | -46.11 Million |
| Investments in PPE | -37.57 Million | -26.01 Million | -17 Million | -25.77 Million | -44.92 Million | -46.42 Million |
| Acquisitions | 469.64 Thousand | 19.14 Million | 9.61 Million | 16.69 Million | 7.64 Million | 37.58 Thousand |
| Investment purchases | -42.14 Thousand | -42.08 Thousand | -38.37 Thousand | -36.08 Thousand | -89.22 Thousand | -44.47 Thousand |
| Sales/Maturities of investments | 18.98 Million | 1.64 Million | -1.48 Million | -3.05 Million | -1.96 Million | -3.39 Million |
| Other Investing Activities | 8.64 Million | -974.32 Thousand | 1.82 Million | 3.57 Million | 3.69 Million | 3.7 Million |
| Financing Cash Flow | -42.69 Million | -56.17 Million | -55.26 Million | -46.5 Million | -30.53 Million | 23.36 Million |
| Debt repayment | -1.6 Million | -1.87 Million | -1.96 Million | -1.95 Million | -62.09 Million | -8.33 Million |
| Dividends payments | - | - | - | - | -2.37 Million | -2.37 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.6 Million | -54.29 Million | -53.29 Million | -44.55 Million | 33.93 Million | 34.07 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -23.58 Million | -49.49 Million | 1.72 Million | 51.87 Million | -6.88 Million | -7.2 Million |
| Cash at beginning of period | 88.03 Million | 120.05 Million | 100.43 Million | 37.24 Million | 33.82 Million | 26.9 Million |
| Cash at end of period | 115.28 Million | 92.27 Million | 120.05 Million | 100.43 Million | 37.24 Million | 33.82 Million |
| Capital Expenditure | -37.57 Million | -26.01 Million | -17 Million | -25.77 Million | -44.92 Million | -46.42 Million |
| Effect of forex changes on cash | 4.23 Million | - | - | -397.38 Thousand | - | - |
| Net cash flow / Change in cash | 27.24 Million | -27.77 Million | 19.61 Million | 63.18 Million | 3.42 Million | 6.92 Million |
| Free Cash Flow | 37.63 Million | 8.62 Million | 64.96 Million | 92.91 Million | 24.66 Million | -16.74 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.99 Million | -1.39 Million | -26.05 Million | -10.77 Million | 10.51 Million | 6.36 Million |
| Depreciation & Amortization | 12.38 Million | 12.09 Million | 47.14 Million | 86 Million | 13.13 Million | 12.76 Million |
| Deferred income taxes | - | - | -65 Thousand | -65 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -16.66 Million | 3.89 Million | -7.18 Million | -23.58 Million | -1.24 Million | -21.52 Million |
| Other non-cash items | 32.07 Million | 25.36 Million | 107.86 Million | 195.64 Million | 4.93 Million | 7.31 Million |
| Investing Cash Flow | 1.34 Million | -2.45 Million | -12.01 Million | -9.51 Million | 4.51 Million | 3.67 Million |
| Investments in PPE | -9.22 Million | -9.14 Million | -12.67 Million | -37.57 Million | -8.76 Million | -8.72 Million |
| Acquisitions | 65.67 Thousand | 226.66 Thousand | 361.03 Thousand | 469.64 Thousand | 17.79 Million | 7.85 Million |
| Investment purchases | - | - | -42.14 Thousand | -42.14 Thousand | - | - |
| Sales/Maturities of investments | 9.5 Million | - | 18.98 Million | 18.98 Million | - | - |
| Other Investing Activities | 1 Million | 6.46 Million | -18.64 Million | 8.64 Million | -4.5 Million | 4.54 Million |
| Financing Cash Flow | -10.98 Million | -10.52 Million | -10.61 Million | -42.69 Million | -11.49 Million | -11.82 Million |
| Debt repayment | -319.3 Thousand | -318.38 Thousand | -369.36 Thousand | -1.6 Million | -470.79 Thousand | -296.85 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -319.3 Thousand | -5.98 Million | -369.36 Thousand | -1.6 Million | -11.02 Million | -11.52 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -16.66 Million | 3.89 Million | -7.18 Million | -23.58 Million | -1.24 Million | -21.52 Million |
| Cash at beginning of period | 118.07 Million | 115.28 Million | 109.64 Million | 88.03 Million | 89.28 Million | 93.36 Million |
| Cash at end of period | 113.45 Million | 118.07 Million | 115.28 Million | 115.28 Million | 109.64 Million | 89.28 Million |
| Capital Expenditure | -9.22 Million | -9.14 Million | -12.67 Million | -37.57 Million | -8.76 Million | -8.72 Million |
| Effect of forex changes on cash | - | - | 848.92 Thousand | 4.23 Million | - | -851.7 Thousand |
| Net cash flow / Change in cash | -4.61 Million | 2.78 Million | 5.64 Million | 27.24 Million | 20.36 Million | -4.08 Million |
| Free Cash Flow | -4.2 Million | 6.61 Million | 14.73 Million | 37.63 Million | 18.57 Million | -3.8 Million |
ICGUF
4951
4300
AJ-R
EXS
4763